CD163L1 and neoplasm: The most upregulated gene in the TdTOSX+;CD45+ subset (>80 fold versus CD45 single positive) was Cd163l1, a marker of gamma-delta IL-17 producing cells (Tan et al., 2019) and M2 macrophages (González-Domínguez et al., 2015), two tumor-promoting immune populations.